• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The development and organization of newborn screening programs in Turkey.土耳其新生儿筛查项目的发展与组织。
J Clin Lab Anal. 2014 Jan;28(1):63-9. doi: 10.1002/jcla.21645. Epub 2013 Dec 27.
2
Expanding the comprehensive national neonatal screening programme in the United Arab Emirates from 1995 to 2011.将阿联酋的全国新生儿综合筛查计划从 1995 年扩大到 2011 年。
East Mediterr Health J. 2014 Feb 11;20(1):17-23.
3
Current status of the congenital hypothyroidism neonatal screening program in Adana Province, Turkey.土耳其阿达纳省先天性甲状腺功能减退症新生儿筛查项目的现状
J Pediatr Endocrinol Metab. 2018 Jun 27;31(6):619-624. doi: 10.1515/jpem-2017-0433.
4
Newborn screening.新生儿筛查
Pathology. 2008 Feb;40(2):104-15. doi: 10.1080/00313020701813743.
5
Austrian Newborn Screening Program: a perspective of five decades.奥地利新生儿筛查项目:五十年的视角
J Perinat Med. 2014 Mar;42(2):151-8. doi: 10.1515/jpm-2013-0113.
6
Screening for congenital hypothyroidism--a new era in Bangladesh.先天性甲状腺功能减退症筛查——孟加拉国的新时代。
Southeast Asian J Trop Med Public Health. 2003;34 Suppl 3:162-4.
7
[Examination of newborn infants in the first week. Techniques and objectives including early and systematic screening of congenital hypothyroidism and phenylketonuria].
Rev Prat. 1991 Feb 1;41(4):357-60.
8
Neonatal screening and monitoring system in Taiwan.台湾的新生儿筛查与监测系统。
Southeast Asian J Trop Med Public Health. 2003;34 Suppl 3:91-3.
9
Newborn screening for congenital hypothyroidism, galactosemia and biotinidase deficiency in Uttar Pradesh, India.印度北方邦先天性甲状腺功能减退症、半乳糖血症和生物素酶缺乏症的新生儿筛查。
Indian Pediatr. 2014 Sep;51(9):701-5. doi: 10.1007/s13312-014-0485-x.
10
Newborn screening and genetic testing.新生儿筛查与基因检测。
J Obstet Gynecol Neonatal Nurs. 2002 Mar-Apr;31(2):200-7. doi: 10.1111/j.1552-6909.2002.tb00041.x.

引用本文的文献

1
The relationship between serum phenylalanine levels, genotype, and developmental assessment test results in non-phenylketonuria mild hyperphenylalaninemia patients.非苯丙酮尿症轻度高苯丙氨酸血症患者血清苯丙氨酸水平、基因型与发育评估测试结果之间的关系
Eur J Pediatr. 2024 Dec 22;184(1):99. doi: 10.1007/s00431-024-05929-1.
2
Comparison of Cost Analysis in Patients with Tetrahydrobiopterin-Responsive and Non-Responsive Phenylketonuria in Turkey.土耳其四氢生物蝶呤反应性与非反应性苯丙酮尿症患者的成本分析比较。
Nutrients. 2024 May 10;16(10):1444. doi: 10.3390/nu16101444.
3
Delays in Newborn Screening for Phenylketonuria from Birth to Diagnosis and Factors Affecting This.从出生到诊断苯丙酮尿症的新生儿筛查延迟及影响因素
Children (Basel). 2024 May 9;11(5):571. doi: 10.3390/children11050571.
4
Out-of-pocket health expenditures in patients living with ınborn errors of metabolism.患有先天性代谢缺陷的患者的自付医疗支出。
Orphanet J Rare Dis. 2023 Jul 6;18(1):179. doi: 10.1186/s13023-023-02775-6.
5
Newborn Screening: From the Past to the Future.新生儿筛查:从过去到未来
Turk Arch Pediatr. 2022 Sep;57(5):473-475. doi: 10.5152/TurkArchPediatr.2022.16082022.
6
Expanded newborn bloodspot screening: developed country examples and what can be done in Turkey.扩大新生儿血斑筛查:发达国家的实例以及土耳其可采取的措施。
Intractable Rare Dis Res. 2022 May;11(2):63-69. doi: 10.5582/irdr.2022.01039.
7
Biochemical screening of intellectually disabled and healthy children in Punjab, Pakistan: differences in liver function test and lipid profiles.巴基斯坦旁遮普省智障儿童和健康儿童的生化筛查:肝功能测试和血脂谱的差异
Int J Dev Disabil. 2019 Jan 15;66(3):190-195. doi: 10.1080/20473869.2018.1533084.
8
A Review of Rare Disease Policies and Orphan Drug Reimbursement Systems in 12 Eurasian Countries.欧亚12国罕见病政策与孤儿药报销体系综述
Front Public Health. 2020 Jan 28;7:416. doi: 10.3389/fpubh.2019.00416. eCollection 2019.
9
The molecular epidemiology of hyperphenylalaninemia in Uygur population: incidence from newborn screening and mutational spectra.维吾尔族人群高苯丙氨酸血症的分子流行病学:新生儿筛查发病率及突变谱
Ann Transl Med. 2019 Jun;7(12):258. doi: 10.21037/atm.2019.05.16.
10
Incidence of Neonatal Hyperphenylalaninemia Based on High-performance Liquid Chromatography Confirmatory Technique in Mazandaran Province, Northern Iran (2007-2015).基于高效液相色谱确证技术的伊朗北部马赞德兰省新生儿高苯丙氨酸血症发病率(2007 - 2015年)
Int J Prev Med. 2017 Nov 7;8:93. doi: 10.4103/ijpvm.IJPVM_24_17. eCollection 2017.

本文引用的文献

1
Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 1. From blood spot to screening result.欧洲的新生儿筛查计划;关于协调的争论和努力。第 1 部分。从血斑到筛查结果。
J Inherit Metab Dis. 2012 Jul;35(4):603-11. doi: 10.1007/s10545-012-9483-0. Epub 2012 May 3.
2
Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 2. From screening laboratory results to treatment, follow-up and quality assurance.欧洲新生儿筛查计划;关于协调的争论和努力。第 2 部分。从筛查实验室结果到治疗、随访和质量保证。
J Inherit Metab Dis. 2012 Jul;35(4):613-25. doi: 10.1007/s10545-012-9484-z. Epub 2012 Apr 28.
3
Expanded newborn screening: social and ethical issues.扩大新生儿筛查:社会和伦理问题。
J Inherit Metab Dis. 2010 Oct;33(Suppl 2):S211-7. doi: 10.1007/s10545-010-9138-y. Epub 2010 Jun 11.
4
Public accountability of newborn screening: collective knowing and deciding.新生儿筛查的公共问责制:集体认知与决策。
Soc Sci Med. 2010 Mar;70(6):926-33. doi: 10.1016/j.socscimed.2009.12.001. Epub 2010 Jan 12.
5
Expanded newborn screening in Europe 2007.2007年欧洲扩大新生儿筛查
J Inherit Metab Dis. 2007 Aug;30(4):439-44. doi: 10.1007/s10545-007-0666-z. Epub 2007 Jul 23.
6
Neonatal screening in Europe; the situation in 2004.欧洲的新生儿筛查;2004年的情况。
J Inherit Metab Dis. 2007 Aug;30(4):430-8. doi: 10.1007/s10545-007-0644-5. Epub 2007 Jul 6.
7
Newborn screening fact sheets.新生儿筛查情况说明书。
Pediatrics. 2006 Sep;118(3):e934-63. doi: 10.1542/peds.2006-1783.
8
International perspectives on newborn screening.新生儿筛查的国际视角。
J Inherit Metab Dis. 2006 Apr-Jun;29(2-3):390-6. doi: 10.1007/s10545-006-0259-2.
9
A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS.一种用于在大量新生儿群体中检测苯丙酮尿症的简易苯丙氨酸方法。
Pediatrics. 1963 Sep;32:338-43.
10
Influence of phenylalanine intake on phenylketonuria.苯丙氨酸摄入对苯丙酮尿症的影响。
Lancet. 1953 Oct 17;265(6790):812-3. doi: 10.1016/s0140-6736(53)90473-5.

土耳其新生儿筛查项目的发展与组织。

The development and organization of newborn screening programs in Turkey.

机构信息

Department of Child and Adolescent Health, Public Health Institution of Turkey, Ankara, Turkey.

出版信息

J Clin Lab Anal. 2014 Jan;28(1):63-9. doi: 10.1002/jcla.21645. Epub 2013 Dec 27.

DOI:10.1002/jcla.21645
PMID:24375520
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6807568/
Abstract

BACKGROUND

Newborn screening tests have been designed to identify infants with severe disorders that are relatively prevalent and treatable or controllable. Comparing to other countries, the incidence of these diseases are very high in Turkey where the rate of consanguineous marriage is high.

METHODS

In this article, it is aimed to evaluate the development and organization of newborn screening programs in Turkey which include phenylketonuria, congenital hypothyroidism and biotinidase deficiency screenings. The point reached today, limitations of the program, expectations and projects for the future are discussed.

RESULTS

Today, the point reached in screening programs of the country is appreciable. While the screening rate of the live born babies was 4,7% in 1987, this rate reached to 95% by 2008. Predicted target for newborn screening program at the strategic plan of Ministry of Health for 2010-2014 was to enhance this rate above 95% by the end of 2012. It seems that the envisaged goal has been reached.

CONCLUSION

National newborn screening program appears to be conducted successfully and extensively as a result of political determination and performance of health care workers who are in charge of this program. Nevertheless, limited numbers of the nutrition and metabolism clinics and specialists on these branches have caused some access difficulties, waste of time, and financial loss. Therefore, special planning to improve quality and the number of the clinics would be useful.

摘要

背景

新生儿筛查测试旨在识别出患有严重疾病的婴儿,这些疾病在土耳其较为普遍,且可治疗或控制。与其他国家相比,土耳其的近亲结婚率较高,因此这些疾病的发病率非常高。

方法

本文旨在评估土耳其新生儿筛查计划的发展和组织,这些计划包括苯丙酮尿症、先天性甲状腺功能减退症和生物素酶缺乏症筛查。讨论了该计划目前的进展、局限性、未来的期望和项目。

结果

如今,该国筛查计划的进展值得赞赏。1987 年,活产婴儿的筛查率为 4.7%,到 2008 年,这一比例达到 95%。卫生部 2010-2014 年战略计划中对新生儿筛查计划的预测目标是到 2012 年底将这一比例提高到 95%以上。似乎已经达到了预期目标。

结论

由于政治决心和负责该计划的医疗保健工作者的表现,国家新生儿筛查计划似乎已成功且广泛开展。然而,营养和代谢诊所以及这些领域的专家数量有限,导致了一些就诊困难、浪费时间和经济损失。因此,进行专门规划以提高诊所的质量和数量将是有益的。